Array BioPharma Inc. : Premium Company Profile
Scope
Report Highlights
Reasons to Purchase
Table of Contents
- Overview - page 1
- Catalyst - page 1
- Summary - page 1
- Table of Contents - page 3
- Table of figures - page 4
- Table of tables - page 5
- Company Structure - page 6
- Company Overview and Key Facts - page 6
- Business Description - page 7
- Landmark Products and Services - page 8
- Array Discovery Platform - page 8
- Landmark Products and Services - page 8
- History - page 9
- Locations and Subsidiaries - page 11
- Company Financials - page 12
- Stock Market Performance - page 12
- P&L - page 13
- Balance Sheet - page 16
- Cash Flow - page 16
- Business Segment Performance - page 17
- Geographic Segment Performance - page 18
- Products & Services - page 19
- Pipeline Products - page 19
- In-house Pipeline - page 19
- ARRY-543 - page 19
- ARRY-797 - page 19
- ARRY-520 - page 20
- ARRY-380 - page 20
- ARRY-614 - page 20
- ARRY-162 - page 20
- In-house Pipeline - page 19
- AC Forecast Product Sales - page 22
- Pipeline Products - page 19
- Competitors and Strategic Business Relationships - page 23
- Key Competitors - page 23
- Key Clients - page 23
- Shareholding Structure - page 24
- Strategy - page 25
- Company View - page 25
- Corporate Strategy - page 30
- SWOT Analysis - page 32
- Overview - page 32
- Strengths - page 33
- Array Discovery Platform - page 33
- Strategic alliances and collaborations - page 33
- Weaknesses - page 35
- Expected decline in revenues - page 35
- Opportunities - page 36
- Out-licensing opportunities - page 36
- Growing cancer and inflammatory disease markets - page 36
- Threats - page 37
- E arly-stage product pipeline - page 37
- Industry consolidation - page 37
- Value Chain Analysis - page 39
- Discovery and Product Development - page 39
- Manufacturing - page 40
- Scorecard - page 41
- Overview - page 41
- Scorecard Analysis - page 42
- Key Employees - page 43
- List of Key Employees - page 43
- Key Employee Biographies - page 44
- Robert E. Conway - page 44
- Kevin Koch - page 44
- David L. Snitman - page 45
- Kyle A. Lefkoff - page 45
- Francis J. Bullock - page 46
- Marvin H. Caruthers - page 46
- Gil J. Van Lunsen - page 47
- Douglas E. Williams - page 47
- John L. Zabriskie - page 48
- R. Michael Carruthers - page 48
- John Yates - page 49
- John R. Moore - page 49
- John A. Josey - page 50
- James D. Winkler - page 50
- Financial and Operational Overview - page 51
- APPENDIX - page 53
- Ask the analyst - page 53
- Datamonitor consulting - page 53
- Disclaimer - page 53
- List of Figures
- Figure 1: Array BioPharma - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) - page 14
Other users found this report page using the following search terms: array biopharma arry162 structure arry520 chemical josey biopharma company john
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.
Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.